CRIS, Curis (formerly CBMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI)

CRIS 1.120

-4.3%

Nov 24 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Harold Engstrom who wrote (100)	1/24/1998 3:00:00 PM
From: Brett Nelson	Read Replies (2) of 668

Thanks for the post, Harold. The article's author suggests a price target of 12-15 if the drug is approved. Unfortunately, I have no idea at what multiples these small, one-product biotech firms trade (although with no appreciable earnings, I'm sure its based on some price to sales ratio). Do you feel this target price range is reasonable given the potential market for the drug? Thanks for your thoughts. Brett Nelson

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next